ArticleFederal practitioner : for the health care professionals of the VA, DoD, and PHS2026
Mental Health Prescribers' Perceptions of Patients With Substance Use Disorders and Harm Reduction Services.
Article in Federal practitioner : for the health care professionals of the VA, DoD, and PHS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Veterans Health Administration (VHA) has published guidelines outlining the legal authority to operate syringe services programs. To aid in the implementation of harm reduction programs at VHA medical centers in Maryland; Washington, DC; and West Virginia, the perceptions of harm reduction tools by mental health prescribers were evaluated. Methods: A mixed-methods analysis examined mental health prescriber perceptions of patients with substance use disorders (SUDs) and their willingness to provide harm reduction tools. A survey was conducted followed by a voluntary postsurvey interview. A descriptive analysis was performed on responses. Notes from postsurvey interviews were analyzed using the Prosci Awareness, Desire, Knowledge, Ability, and Reinforcement (ADKAR) Model for Change Management. Results: Prescribers felt comfortable and confident in their abilities to educate patients to reduce harm related to substance use. Survey results were mixed regarding comfort in working with people with or without SUDs. Prescribers were represented across the continuum of the ADKAR change model and were more willing to provide naloxone than fentanyl test strips or syringes. Prescribers expressed mixed opinions on the use of harm reduction tools for patients with SUDs. Some prescribers viewed harm reduction as part of a treatment plan, while others viewed a return to drug use as a failure of treatment. Conclusions: This study highlights the need for additional interventions to address clinician hesitancy and concerns surrounding harm reduction tools to successfully implement harm reduction programs across the VHA.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.